Topical dutasteride is considered more effective for hair regrowth with fewer side effects than oral finasteride. Users have mixed experiences, with some preferring topical applications for reduced side effects.
Finasteride can help maintain hair and slow hair loss, but its effectiveness varies by individual. Some may switch to dutasteride or add minoxidil for better results, though side effects are a concern.
Diet and lifestyle changes can reduce hair shedding but won't regrow hair lost to genetic male pattern baldness. Treatments like finasteride and dutasteride are necessary for significant hair regrowth.
A 20-year-old engineering student discusses balding experiences with barbers, mentioning treatments like PRP and rosemary oil masks, which slowed but didn't stop hair loss. The conversation humorously touches on the stereotype of engineers balding due to stress and suggests considering treatments like finasteride.
The user is concerned about hair loss and is unsure whether to trust their dermatologist's prescription of minoxidil, fearing potential hormonal effects. Other users suggest using finasteride to block DHT and recommend a blood test to check for underlying issues, while advising against relying solely on shampoos for hair loss treatment.
The user used minoxidil unnecessarily for two months due to a perceived hair loss but realized their hairline hadn't changed in 2.5 years. They are concerned about shedding caused by minoxidil and whether stopping its use will allow regrowth or cause permanent damage.
The user achieved significant hair regrowth using dutasteride 0.5mg for a year and oral minoxidil 2.5mg for eight months, despite initial shedding. They reported no side effects and preferred oral treatments over topicals.
A 21-year-old is experiencing aggressive hair loss despite using minoxidil, dutasteride, and GFC, and is seeking advice on whether to switch treatments or consider a hair transplant. Suggestions include continuing current treatments, checking for underlying health issues, and considering alternatives like RU58841 or microneedling.
A 26-year-old man shared his positive results after 10 months of treating male pattern baldness using a regimen that includes Estradiol Enanthate, DHPA, Bicalutamide, Dutasteride, oral and topical Minoxidil, and a dermaroller. He experienced mild gynecomastia and reduced body hair as side effects but was satisfied with the outcome.
PP405 shows significantly better early-stage hair regrowth results compared to minoxidil and finasteride, with 31% of users experiencing over 20% density increase in 4–8 weeks. Minoxidil and finasteride show minimal or no visible regrowth in the same timeframe.
Dutasteride is effective for many in reducing hair loss and promoting regrowth, often with fewer side effects than finasteride. Combining it with minoxidil is commonly seen as a successful strategy, though results may take several months.
Hair cloning for hair loss is unlikely to be available or affordable in the next 10 years. Current treatments like Minoxidil, finasteride, and RU58841 are still the main options, with skepticism about new advancements.
The user has been using dutasteride and oral minoxidil for over three years with good results and is seeking additional treatments to improve hair growth by 10-15%. Suggestions include derma stamping, red light therapy, deep massage, caffeinated shampoos, and biotin supplementation.
PP405 is seen as promising but uncertain, with users advised to continue using existing treatments like minoxidil and finasteride. Concerns include its cost, availability, and interaction with hair transplants, while some hope it could complement current treatments.
Finasteride and Dutasteride will remain accessible in the EU despite objections from France and Belgium. Users discuss the ease of obtaining these medications in different countries and express relief and support for the EU's decision.
A 25-year-old male experienced hair regrowth after switching from topical minoxidil to a combination of topical minoxidil and oral finasteride, along with microneedling and multivitamins. He reported no significant side effects from finasteride, except mild discomfort, and emphasized the effectiveness of oral finasteride over topical solutions.
PP405 is progressing to Phase 2b trials, with results expected in late 2025 or early 2026, and potential Phase 3 trials in 2026. Some users experienced side effects from finasteride and are hopeful for PP405 as an alternative treatment.
Gut microbiota significantly influences androgen metabolism, impacting hair loss treatments like finasteride. Probiotics, dietary changes, and fecal microbiota transplants may help manage DHT levels and improve hair health.
Hair regrowth using oral finasteride and topical minoxidil, with significant improvement after three months. Some users experienced side effects like bloating and dark circles, and discussed alternative treatments like microneedling and natural oils.
The user has been using finasteride, oral minoxidil, topical minoxidil, and Nizoral for hair loss and noticed texture improvement but is unsure about density changes. Other users discuss the importance of taking progress photos with dry hair and share their own experiences and advice.
The user shared progress pictures showing hair improvement after using 1mg oral finasteride and topical minoxidil daily for three months. They experienced initial side effects but reported no issues after five weeks, and the conversation includes discussions on the effectiveness and side effects of these treatments.
Finasteride improved hair thickness for someone with diffused thinning after 11 months, with no side effects. Patience and consulting a dermatologist are advised, and minoxidil is suggested for additional support.
Blocking DHT is not a cure for hair loss; instead, altering how scalp follicles respond to DHT might be more effective. Current treatments like topical finasteride and minoxidil are temporary solutions, and future approaches may involve gene therapy and bioengineering to change follicle behavior.
Blocking DHT is not a complete solution for hair loss; instead, altering the scalp's response to DHT may be more effective. Topical finasteride and minoxidil are current treatments, but future approaches may involve bioengineering, gene therapy, and inflammation control.
The conversation is about someone planning to start finasteride for hair loss and wanting to interpret pre-treatment blood panels to assess the risk of side effects like gynecomastia. They list various tests to measure hormone levels and other health indicators.
The user is experiencing increased thinning around the crown after starting topical Minoxidil and is considering switching from Finasteride to Dutasteride. Responses suggest the thinning might be a temporary shedding phase due to the new treatment, and it's advised to continue the current regimen and monitor progress.
Developing new hair loss treatments is challenging due to the complexity and cost of trials, and a permanent cure is unlikely soon. Current treatments like Minoxidil and finasteride are used continuously because hair loss is progressive, and future possibilities include gene editing and hair cloning.
A 30-year-old woman with a history of anemia and low vitamin D experienced hair shedding, which improved after addressing nutrient deficiencies. Despite regrowth of terminal hairs, her dermatologist recommended treatments like minoxidil and spironolactone to prevent future bald spots, but she is cautious due to family history of hormone-related cancers.
Minoxidil and LLLT are compared for treating hair loss, with LLLT showing higher regrowth rates and fewer side effects. LLLT is less time-consuming and more suitable for those with health issues, while Minoxidil requires daily application.